Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
3 min read
Tenaya Therapeutics receives FDA approval to initiate the clinical trial of TN-401 gene therapy for treating PKP2-related Arrhythmogenic Right Ventricular Cardiomyopathy
31 October 2023
Tenaya Therapeutics, a clinical-phase biotech firm focusing on heart disease treatments, announced today they've received FDA approval for their IND application to begin clinical trials for TN-401.
Drug Insights
4 min read
Exploring Camrelizumab's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
31 October 2023
This article summarized the latest R&D progress of Camrelizumab, the Mechanism of Action for Camrelizumab, and the drug target R&D trends for Camrelizumab.
Bio Sequence
2 min read
Biological Glossary | What is Cyclopeptide?
31 October 2023
A cyclopeptide is a type of peptide in which the amino acid sequence forms a cyclic rather than a linear structure.
Latest Hotspot
3 min read
Mustang Bio confirms that FDA has approved the IND application for MB-109, aimed at treating recurrent Glioblastoma and High-Grade Astrocytoma
31 October 2023
Mustang Bio, Inc., a biopharmaceutical firm conducting clinical trials and developing cell and gene therapies for difficult cancers and rare genetic diseases, announced FDA approval of their IND application for MB-109.
Bio Sequence
2 min read
Biological Glossary | What is Conserved Sequence?
31 October 2023
In biology, conserved sequences refer to molecular sequences with high similarity or identity.
Drug Insights
3 min read
Decoding Casirivimab: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
31 October 2023
This article summarized the latest R&D progress of Casirivimab, the Mechanism of Action for Casirivimab, and the drug target R&D trends for Casirivimab.
Bio Sequence
3 min read
Toripalimab: FDA Greenlights First made-in-China PD-1 and Its Evolving Competitive Landscape
31 October 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the toripalimab patent are as follows: Shanghai Junshi Biosciences with 52 applications, Cugene with 30 applications, and Guangzhou Zhiyi Biotech with 16 applications. For more applicants, please refer to the image below.
Drug Insights
4 min read
An In-depth Analysis of Cephradine's R&D Progress and Mechanism of Action on Drug Target
30 October 2023
This article summarized the latest R&D progress of Cephradine, the Mechanism of Action for Cephradine, and the drug target R&D trends for Cephradine.
Latest Hotspot
3 min read
CSPC Pharmaceutical Group's Claudin6/CD137 Dual Antibody NBL-028 has been approved for clinical trials, aimed at treating late-stage solid tumors
30 October 2023
Recently, CSPC Pharmaceutical announced that its independently developed bispecific antibody targeting Claudin6/CD137, NBL-028, has received approval from the National Medical Products Administration (NMPA) in China for clinical trial applications.
Drug Insights
4 min read
Cilnidipine: Detailed Review of its Transformative R&D Success
30 October 2023
This article summarized the latest R&D progress of Cilnidipine, the Mechanism of Action for Cilnidipine, and the drug target R&D trends for Cilnidipine.
Bio Sequence
2 min read
Biological Glossary | What is Consensus Sequence?
30 October 2023
In molecular biology and bioinformatics, a consensus sequence is a sequence of DNA, RNA, or protein that represents the most common or typical sequence found in a specific location within a population.
Drug Insights
4 min read
Benzydamine Hydrochloride Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
30 October 2023
This article summarized the latest R&D progress of Benzydamine Hydrochloride, the Mechanism of Action for Benzydamine Hydrochloride, and the drug target R&D trends for Benzydamine Hydrochloride.